Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer in Iron-Deficient Blood Donors
NCT01895231Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Pharmacosmos. Started Jun 2013; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01895231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895231.